Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Colleoni, Marco; Luo, Weixiu; Karlsson, Per; et al; Aebi, Stefan; Ruhstaller, Thomas; Ribi, Karin; Bernhard, Jürg; Maibach, Rudolf; Rabaglio-Poretti, Manuela (2018). Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 19(1):127-138.

Pestalozzi, Bernhard C; Tausch, Christoph; Dedes, Konstantin J; Rochlitz, Christoph; Zimmermann, Stefan; von Moos, Roger; Winterhalder, Ralph; Ruhstaller, Thomas; Mueller, Andreas; Buser, Katharina; Borner, Markus; Novak, Urban; Nussbaum, Catrina Uhlmann; Seifert, Bettina; Bigler, Martin; Bize, Vincent; Vilei, Simona Berardi; Rageth, Christoph; Aebi, Stefan; Swiss Group for Clinical Cancer Research (SAKK) (2017). Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). BMC Cancer, 17(1):265.

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver; Swiss Group for Clinical Cancer Research (SAKK) (2016). A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. Journal of Thoracic Oncology, 11(11):1846-1855.

Hofer, Silvia; Mengele, Karin; Schmitt, Manfred; Pestalozzi, Bernhard; Aebi, Stefan (2015). Complement activation and rituximab distribution in CNS NHL: letter. Clinical Cancer Research, 21(2):490.

This list was generated on Wed Jun 19 02:48:16 2019 CEST.